Company intelligence / Profile preview

Heng Feng Investments (International) Limited

Hong Kong, China (Hong Kong SAR)

Ownership: Private
Development stage: Other

Overview

Heng Feng Investments (International) is a Hong Kong based investment holding company primarily focused on private equity and M&A, including selective activity as a consortium member in healthcare/biotech transactions such as the 2016 Sinovac Biotech acquisition offer. There is no evidence of its own clinical-stage programs or drug development.

Industry: Investors

Partnerships

Consortium member in Sinovac Biotech acquisition proposal (with Sinobioway Group, PKU V-Ming, Fuerde Global Investment, others)

Beyond the preview

Go deeper on Heng Feng Investments (International) Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heng Feng Investments (International) Limited.

Explore the full profile